Company intelligence / Profile preview

KOBOTAMA

Solapur, Maharashtra, Indiafr.linkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Kobo Biotech was an Indian manufacturer specializing in active pharmaceutical ingredients (APIs) and key starting materials using fermentation technology. The company supplied products to multiple countries and maintained technical documentation for regulatory compliance. As of November 2024, the company entered corporate insolvency resolution proceedings due to financial distress.

Therapeutic areas: Other
Modalities: Small moleculeFermentation-based biologics
Industry: Contract Manufacturing Organization

Partnerships

Historical technology transfer agreements with Shanghai Machinery & Equipment Import & Export Corporation/Shanghai Peng Pu Chemical Works and Xytel Technologies Partnership USA during its earlier incarnation as Avon Organics Limited

Beyond the preview

Go deeper on KOBOTAMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KOBOTAMA.

Explore the full profile